ABBOTT LABORATORIES (ABT) capitalization

Current snapshot

Market Cap
$177.04B
1.75B shares × $101.88
Net Worth
$52.13B
Stockholders' equity · 2025-12-31
Enterprise Value
$182.23B
Market cap + debt − cash
Net Debt
$5.20B
Debt $14.14B − Cash $8.94B

Annual history

One row per fiscal year (10-K). Market cap uses split-adjusted closing price on the fiscal-year-end date × shares outstanding.

Period End Market Cap
FY'25 2025-12-31 $219.01B
FY'24 2024-12-31 $197.72B
FY'23 2023-12-31 $192.51B
FY'22 2022-12-31 $193.67B
FY'21 2021-12-31 $251.78B
FY'20 2020-12-31 $195.55B
FY'19 2019-12-31 $154.70B
FY'18 2018-12-31 $128.02B
FY'17 2017-12-31 $99.82B
FY'16 2016-12-31 $56.96B
FY'15 2015-12-31 $67.63B
FY'14 2014-12-31 $68.75B
FY'13 2013-12-31 $60.33B
FY'12 2012-12-31 $104.28B
FY'11 2011-12-31 $88.11B
FY'10 2010-12-31 $74.55B
FY'09 2009-12-31 $83.96B

Quarterly history

One row per quarter (10-Q and Q4 from 10-K). Market cap uses split-adjusted closing price on the quarter-end date × shares outstanding.

Period End Market Cap
Q4'25 2025-12-31 $219.01B
Q3'25 2025-09-30 $234.31B
Q2'25 2025-06-30 $238.13B
Q1'25 2025-03-31 $231.77B
Q4'24 2024-12-31 $197.72B
Q3'24 2024-09-30 $199.24B
Q2'24 2024-06-30 $181.96B
Q1'24 2024-03-31 $198.87B
Q4'23 2023-12-31 $192.51B
Q3'23 2023-09-30 $169.32B
Q2'23 2023-06-30 $190.81B
Q1'23 2023-03-31 $177.38B
Q4'22 2022-12-31 $193.67B
Q3'22 2022-09-30 $170.65B
Q2'22 2022-06-30 $191.82B
Q1'22 2022-03-31 $210.03B
Q4'21 2021-12-31 $251.78B
Q3'21 2021-09-30 $211.33B
Q2'21 2021-06-30 $207.89B
Q1'21 2021-03-31 $214.69B
Q4'20 2020-12-31 $195.55B
Q3'20 2020-09-30 $194.57B
Q2'20 2020-06-30 $163.21B
Q1'20 2020-03-31 $140.51B
Q4'19 2019-12-31 $154.70B
Q3'19 2019-09-30 $149.28B
Q2'19 2019-06-30 $149.82B
Q1'19 2019-03-31 $142.02B
Q4'18 2018-12-31 $128.02B
Q3'18 2018-09-30 $129.97B
Q2'18 2018-06-30 $107.89B
Q1'18 2018-03-31 $105.78B
Q4'17 2017-12-31 $99.82B
Q3'17 2017-09-30 $93.60B
Q2'17 2017-06-30 $85.01B
Q1'17 2017-03-31 $77.06B
Q4'16 2016-12-31 $56.96B
Q3'16 2016-09-30 $62.44B
Q2'16 2016-06-30 $58.20B
Q1'16 2016-03-31 $62.06B
Q4'15 2015-12-31 $67.63B
Q3'15 2015-09-30 $60.54B
Q2'15 2015-06-30 $73.83B
Q1'15 2015-03-31 $70.21B
Q4'14 2014-12-31 $68.75B
Q3'14 2014-09-30 $63.21B
Q2'14 2014-06-30 $62.05B
Q1'14 2014-03-31 $59.60B
Q4'13 2013-12-31 $60.33B
Q3'13 2013-09-30 $52.00B
Q2'13 2013-06-30 $54.99B
Q1'13 2013-03-31 $56.02B
Q4'12 2012-12-31 $104.28B
Q3'12 2012-09-30 $109.30B
Q2'12 2012-06-30 $102.41B
Q1'12 2012-03-31 $97.42B
Q4'11 2011-12-31 $88.11B
Q3'11 2011-09-30 $80.20B
Q2'11 2011-06-30 $82.41B
Q1'11 2011-03-31 $76.45B
Q4'10 2010-12-31 $74.55B
Q3'10 2010-09-30 $81.18B
Q2'10 2010-06-30 $72.59B
Q1'10 2010-03-31 $82.25B
Q4'09 2009-12-31 $83.96B
Q3'09 2009-09-30 $76.80B
Q2'09 2009-06-30 $72.94B
Q1'10 2009-03-31 $74.24B
Q2'09 2008-12-31 $83.30B
Q3'09 2008-09-30 $90.04B
Q2'09 2008-06-30 $82.28B
Q2'09 2007-12-31 $87.60B

Methodology

Every figure on this page traces back to SEC EDGAR XBRL company-facts filings (ABT CIK 0000001800), tagged with the us-gaap and dei taxonomies. The only exception is the live market cap tile, which uses the current share price × shares outstanding from a market quote. Historical share prices come from our total-returns daily history (split-adjusted); historical market caps are calibrated against today's share count to correct for SEC retroactive split restatements.

For the exact XBRL concepts and formulas, see the methodology reference for net worth, debt, cash, market cap, enterprise value, net debt, shares outstanding, and the historical-market-cap calibration.